Clinical Trial Update: Predicting Outcomes in ICH Patients on Direct Factor Xa Inhibitors

View source ↗

Summary

A clinical trial is evaluating outcome prediction for intracerebral hemorrhage patients who are taking direct Factor Xa inhibitors, with recruitment currently o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracerebral Hemorrhage

Drugs mentioned

• Apixaban (apixaban)
• Edoxaban (edoxaban)
• Rivaroxaban (rivaroxaban)
• betrixaban (betrixaban)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Intra Cerebral Hemorrhage | Status: RECRUITING